X-ZELL global HQ now open for business in Singapore Singapore, May 2019 – X-ZELL, only recently named one of Asia’s 20 most innovative health tech start-ups, today opened its new global headquarters at Paya Lebar Square in Singapore, conveniently located between...
X-ZELL shortlisted for 2019 HealthInvestor Asia Award Singapore, April 2019 – Rare cell detection specialist, X-ZELL, has been shortlisted as a Finalist for the 2019 HealthInvestor Asia Awards. According to HealthInvestor Asia, X-ZELL has been nominated in the...
X-ZELL Cryoimmunostaining™ World Premiere Singapore, February 2019 – Rare cell detection specialist X-ZELL is proud to announce the world premiere of the world’s first 8-channel multiplexing technology, Cryoimmunostaining™ . Originally designed to enable the company’s...
X-ZELL Cryoimmunostaining™ Suite to feature at Medlab Asia 2019 Singapore, February 2019 – Singaporean medical technology start-up X-ZELL will preview the production version of the world’s first slide-based, eight-channel immunostaining solution at the 2019...
X-ZELL signs research collaboration agreement with Diagnostics Development Hub X-ZELL is now officially partnering with Singapore’s DxD Hub. Singapore, December 2018 – In a move that will accelerate the company’s capabilities and scale up its...
X-ZELL CEO presenting breakthrough CEC research at EMUC18 Amsterdam, November 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has used the 2018 European Multidisciplinary Congress on Urological Cancers (EMUC18) in Amsterdam as a platform to present new insights into the...
